top of page

The Professional Network for Healthcare Experts

Express Interest

Buscar

Merck’s $6.7B Terns Deal Shows Big Pharma Is Preparing for Patent Cliffs

nuaxia

30 jul

0 min de lectura

Entradas relacionadas

Novotech agrees acquisition of Agilex Biolabs to expand bioanalytical capabilities in Australia

Novotech agrees acquisition of Agilex Biolabs to expand bioanalytical capabilities in Australia

Samsung Bioepis and Teva expand biosimilars partnership to up to six candidates

Samsung Bioepis and Teva expand biosimilars partnership to up to six candidates

Sanofi and Regeneron expand immunology alliance in deal worth up to $8bn

Sanofi and Regeneron expand immunology alliance in deal worth up to $8bn

bottom of page